BerandaREGN34 • BVMF
add
Regeneron Pharmaceuticals Inc BDR
Tutup sebelumnya
R$55,96
Rentang tahun
R$52,26 - R$111,62
Kapitalisasi pasar
65,90Â M USD
Volume Rata-Rata
99,00
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 3,03Â M | -3,70% |
Biaya operasional | 633,00Â jt | -8,13% |
Laba bersih | 808,70Â jt | 12,01% |
Margin laba bersih | 26,70 | 16,29% |
Penghasilan per saham | 8,22 | -13,93% |
EBITDA | 730,90Â jt | -17,68% |
Tarif pajak efektif | 10,64% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 8,35Â M | -20,63% |
Total aset | 37,55Â M | 9,24% |
Total liabilitas | 8,16Â M | 10,56% |
Total ekuitas | 29,39 M | — |
Saham yang beredar | 105,67 jt | — |
Harga terhadap nilai buku | 0,20 | — |
Tingkat pengembalian aset | 4,01% | — |
Tingkat pengembalian modal | 4,69% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 808,70Â jt | 12,01% |
Kas dari operasi | 1,05Â M | -30,90% |
Kas dari investasi | 647,50Â jt | 138,38% |
Kas dari pembiayaan | -1,09Â M | -2.412,53% |
Perubahan kas bersih | 604,00Â jt | 571,88% |
Arus kas bebas | 561,86Â jt | -49,60% |
Tentang
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
Didirikan
1988
Kantor pusat
Situs
Karyawan
15.158
